OCRA Featured in Fortune on Surgery That Reduces Ovarian Cancer Risk
A Fortune article published on June 16, 2025, titled I had one simple surgery to lower my risk of the deadliest cancer for women. Here’s why you probably don’t know … Continued
OCRA Corporate Sponsors & Partners
Corporate Sponsors
We are deeply grateful to our past and current corporate partners for supporting our mission to find a cure and improve the lives of those affected by ovarian and other gynecologic cancers.
Corporate Partners
Conflict of Interest Statement — Industry Partners
- Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
- In 2023, industry partners represented 8% of OCRA’s overall revenue.
- If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
- Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.
Related Topics
Ovarian Cancer Research Alliance Partners with Iris by OncoHealth to Expand Access to the Steps Counseling Program
New collaboration enhances support for gynecologic cancer patients through integrated digital and personalized care New York, NY — [June 11, 2025] — Ovarian Cancer Research Alliance (OCRA), the largest global organization … Continued
The Overview: May 2025
Global Collaborative Research Push Resonates Across Airwaves The launch of the Global Ovarian Cancer Research Consortium has garnered significant media attention, with coverage appearing on NBC News Radio, FOX 5 Washington D.C., KUNS-TV … Continued